FREE CONSULTATION (713) 621-7944

Blog

The Dangerous Consequences of Rushing a Drug to Market: Elmiron®

June 16, 2020 · FLEMING | NOLEN | JEZ, L.L.P.

The FDA must approve a prescription drug before the manufacturer can sell it in the United States. Ordinarily, the approval process requires that the manufacturer first present clinical trial data as evidence for the effectiveness and safety of the drug. If a drug is too dangerous, or if the drug is not effective in treating the condition for which it…
read more